173 related articles for article (PubMed ID: 221088)
1. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
2. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of human lung cancer with BCG cell-wall skeleton.
Yasumoto K; Manabe H; Ueno M; Ohta M; Ueda H
Gan; 1976 Dec; 67(6):787-95. PubMed ID: 798710
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of the patients with malignant pleural effusion with BCG cell-wall skeleton.
Yamamura Y; Ogura T; Yoshimoto T; Nishikawa H; Sakatani M
Gan; 1976 Oct; 67(5):669-77. PubMed ID: 797625
[TBL] [Abstract][Full Text] [Related]
6. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
Nishikawa H; Yasaki S; Yoshimoto T; Sakatani M; Itoh M; Masuno T; Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
[TBL] [Abstract][Full Text] [Related]
7. [Cellular changes in malignant pleural effusion induced by intrapleural injection of BCG-CWS].
Matsuda M; Morishita T; Horai T; Ikegami H; Nakamura S; Nishio H
Gan No Rinsho; 1983 Aug; 29(9):955-61. PubMed ID: 6620573
[TBL] [Abstract][Full Text] [Related]
8. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
Ogura T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural BCG in operable lung cancer.
Lowe J; Iles PB; Shore DF; Langman MJ; Baldwin RW
Lancet; 1980 Jan; 1(8158):11-4. PubMed ID: 6101353
[TBL] [Abstract][Full Text] [Related]
11. Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study.
Kodama K; Higashiyama M; Takami K; Oda K; Okami J; Maeda J; Akazawa T; Matsumoto M; Seya T; Wada M; Toyoshima K
Surg Today; 2009; 39(3):194-200. PubMed ID: 19280277
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
Morishita M
Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
[No Abstract] [Full Text] [Related]
13. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
[No Abstract] [Full Text] [Related]
14. A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer.
Shibata T; Takata E; Sakamoto J; Shioya A; Yamada S; Takakura M; Sasagawa T
Medicine (Baltimore); 2022 Dec; 101(52):e32481. PubMed ID: 36595982
[TBL] [Abstract][Full Text] [Related]
15. [Effect of adjuvant immunotherapy with Nocardia rubra cell-wall skeleton in lung cancer].
Yasumoto K; Ichinose Y; Yaita H; Tanaka K; Hara N; Ohta M; Hirota N; Nomoto K; Inokuchi K; Yamamura Y
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):321-7. PubMed ID: 6325864
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
[TBL] [Abstract][Full Text] [Related]
17. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.
Masuda H; Nakamura T; Noma Y; Harashima H
Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885
[TBL] [Abstract][Full Text] [Related]
18. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
[TBL] [Abstract][Full Text] [Related]
19. Immune status in lung cancer: effects of BCG immunotherapy.
Gross NJ; Eddie-Quartey AC
Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
[TBL] [Abstract][Full Text] [Related]
20. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
